AxoGen Invests $5M in Dayton, Ohio, Site for Expanded Operations

AxoGen Invests $5M in Dayton, Ohio, Site for Expanded Operations (Dayton Daily News)

UF startup and UF Innovate | Sid Martin Biotech alum AxoGen, a medical devices manufacturer, has purchased a Vandalia building and land for $5 million for nerve graft work. AxoGen Inc., its principal executive office located in Alachua, bought the 2,400-square-foot building at 913 Industrial Park for $5 million, Montgomery County property records show.

Just over eight acres of land was also part of the purchase.

“The company completed the acquisition of a facility near our current leased facility in Dayton, Ohio, where we will transition our existing processing to support our long-term capacity needs,” AxoGen Inc. said in a release earlier this month.

The company has had a presence in Dayton for about three years, working in the Community Blood Center in downtown Dayton, where AxoGen employees lease space, said Diane Wilson, the center’s chief operating officer.

Learn more about AxoGen Invests $5M in Dayton, Ohio, Site for Expanded Operations.

X